BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28008570)

  • 1. The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma.
    Ierardi AM; Angileri SA; Patella F; Panella S; Lucchina N; Petre EN; Pinto A; Franceschelli G; Carrafiello G; Cornalba G; Sofocleous CT
    Med Oncol; 2017 Jan; 34(1):11. PubMed ID: 28008570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional radiology approaches for intra-hepatic cholangiocarcinoma.
    Mosconi C; Calandri M; Javle M; Odisio BC
    Chin Clin Oncol; 2020 Feb; 9(1):8. PubMed ID: 32008330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
    Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.
    Mosconi C; Cappelli A; Ascanio S; Pettinari I; Modestino F; Renzulli M; Galaverni MC; Cucchetti A; Gramenzi A; Pettinato C; Golfieri R
    Future Oncol; 2017 Jun; 13(15):1301-1310. PubMed ID: 28343412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
    Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma.
    Hong K; Geschwind JF
    Semin Oncol; 2010 Apr; 37(2):110-7. PubMed ID: 20494703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting outcomes of Yttrium-90 radioembolization in heavily pretreated patients with intrahepatic cholangiocarcinoma.
    Zhao K; Erinjeri JP; Sotirchos VS; Alexander ES; Moussa AM; Marinelli B; Ziv E; Sofocleous CT; Abou-Alfa GK; Jarnagin WR; Karimi A; Yarmohammadi H
    Abdom Radiol (NY); 2023 Jul; 48(7):2434-2442. PubMed ID: 37145313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective Study.
    Bargellini I; Mosconi C; Pizzi G; Lorenzoni G; Vivaldi C; Cappelli A; Vallati GE; Boni G; Cappelli F; Paladini A; Sciuto R; Masi G; Golfieri R; Cioni R
    Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1305-1314. PubMed ID: 32642986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional therapy for cholangiocarcinoma.
    Kuhlmann JB; Blum HE
    Curr Opin Gastroenterol; 2013 May; 29(3):324-8. PubMed ID: 23337933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
    Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
    Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option.
    Saxena A; Bester L; Chua TC; Chu FC; Morris DL
    Ann Surg Oncol; 2010 Feb; 17(2):484-91. PubMed ID: 19876691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Locoregional and local ablative treatment options for liver tumors].
    Hinrichs JB; Wacker FK
    Internist (Berl); 2020 Feb; 61(2):158-163. PubMed ID: 31919532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis.
    Edeline J; Lamarca A; McNamara MG; Jacobs T; Hubner RA; Palmer D; Groot Koerkamp B; Johnson P; Guiu B; Valle JW
    Cancer Treat Rev; 2021 Sep; 99():102258. PubMed ID: 34252720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study.
    Mosconi C; Gramenzi A; Ascanio S; Cappelli A; Renzulli M; Pettinato C; Brandi G; Monari F; Cucchetti A; Trevisani F; Golfieri R
    Br J Cancer; 2016 Jul; 115(3):297-302. PubMed ID: 27336601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An emerging role for radiation therapy in the treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Wo JY; Dawson LA; Zhu AX; Hong TS
    Surg Oncol Clin N Am; 2014 Apr; 23(2):353-68. PubMed ID: 24560114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology.
    Fabritius MP; Ben Khaled N; Kunz WG; Ricke J; Seidensticker M
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of cholangiocarcinoma.
    Singh MK; Facciuto ME
    Mt Sinai J Med; 2012; 79(2):232-45. PubMed ID: 22499494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
    Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
    Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report--intrahepatic arterial infusion with CDDP and S-1 administration can elicit long-term survival for the patient with recurrenced intrahepatic cholangiocarcinoma after resection].
    Tanida T; Tanemura M; Kobayashi S; Wada H; Marubashi S; Eguchi H; Takeda Y; Umeshita H; Mori M; Doki Y; Nagano H
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2729-31. PubMed ID: 21224694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management.
    Zhang H; Yang T; Wu M; Shen F
    Cancer Lett; 2016 Sep; 379(2):198-205. PubMed ID: 26409434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.